4th Annual Commercializing Flow Chemistry Summit

Welcome to the 4th Annual Commercializing Flow Chemistry Summit! This highly anticipated event brings together over 100 process chemists, engineering experts, and modelers from the pharmaceutical industry for a comprehensive exploration of flow chemistry's transformative potential.

Over the past year, flow chemistry has experienced exponential growth, thanks to groundbreaking proof-of-concept milestones achieved by industry leaders such as Phlow. Additionally, the introduction of new ICH Q13 guidelines has further propelled the adoption of flow chemistry techniques. Companies like AbbVie, AstraZeneca, Merck, and BMS have contributed to the field's rapid advancement, solidifying its position as a key driver in the future of drug discovery and development.

With the global Flow Chemistry Market projected to reach a value of USD 3.2 Billion by 2030, there is a growing emphasis on designing active compounds and implementing efficient synthesis techniques. As a result, investment in flow chemistry technology is on the rise. The 4th annual Commercializing Flow Chemistry Summit aims to provide process development professionals with a masterclass in harnessing the power of flow chemistry to add tangible value across all stages of the drug development process.

This year's summit will specifically focus on increasing scalability and process intensification in flow chemistry. By addressing these critical areas, attendees will gain insights into enhancing sustainability, reducing costs of goods, and driving innovation in drug discovery. The event will feature multiple deep-dive discussions, where industry trends and challenges will be actively explored.

As the only summit dedicated to novel reaction and advanced scale-up techniques, the agenda boasts 18+ case studies driven by biopharmaceutical companies. These in-depth sessions will delve into the latest applications of photochemistry, electrochemistry, and mechanochemistry, with prominent industry players such as Eli Lilly, Genentech, and Pfizer showcasing how they utilize flow chemistry to transform drug development.

The summit's program seamlessly combines technical content with informative case study sessions, empowering attendees to expand their emerging technology toolbox. By participating in this event, you will gain actionable insights that can be applied directly to your team's processes and contribute to the advancement of flow chemistry in the pharmaceutical industry.

Join us at the 4th Annual Commercializing Flow Chemistry Summit and become part of the global movement shaping the future of drug discovery and development through strategic flow chemistry.